Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLCBCYC · Entity 5993 | Director · CHIEF EXECUTIVE OFFICER | October 02, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BICYCLE THERAPEUTICS PLC
Report date October 02, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 595,866 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-02 · Sale · Disposed 6,167 · Balance 597,504 F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-10-05 · Sale · Disposed 1,638 · Balance 595,866 F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting and settlement of the RSUs. This sale is mandated by the Reporting Person's award agreement that requires the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.525 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.56 to $3.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2021 Filed Aug 31, 2021 21:29 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 1,808 | $36.02 | $65,124.16 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:29 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 1,808 | $14.00 | $25,312.00 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 100 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,370 Underlying: Ordinary Shares · 100 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 26, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 100 | $36.00 | $3,600.00 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 26, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 100 | $14.00 | $1,400.00 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 4,782 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · derivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,470 Underlying: Ordinary Shares · 4,782 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 4,782 | $36.02 | $172,247.64 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.21 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 23:08 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 4,782 | $14.00 | $66,948.00 |
DisclosureSEC source: 0001209191-21-048348 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 609 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,252 Underlying: Ordinary Shares · 609 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 609 | $34.00 | $20,706.00 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 16, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 609 | $14.00 | $8,526.00 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 21,970 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · derivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,861 Underlying: Ordinary Shares · 21,970 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 21,970 | $34.28 | $753,131.60 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 22:27 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 21,970 | $14.00 | $307,580.00 |
DisclosureSEC source: 0001209191-21-046996 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 8,331 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · derivative · entry 14 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,831 Underlying: Ordinary Shares · 8,331 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 53 | $35.16 | $1,863.48 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 11 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 9,084 | $34.89 | $316,940.76 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 10 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,138 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.16 to $35.11 inclusive. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 2,686 | $33.85 | $90,921.10 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 9 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,222 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.15 to $34.12 inclusive. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 2,642 | $32.93 | $87,001.06 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 8 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,908 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.15 to $33.14 inclusive. Read SEC document |
| July 14, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 8,331 | $14.00 | $116,634.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 7 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 35,446 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · derivative · entry 13 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,162 Underlying: Ordinary Shares · 35,446 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 11,194 | $34.00 | $380,596.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,219 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 5,788 | $33.09 | $191,524.92 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,413 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 21,979 | $32.42 | $712,559.18 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,201 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.98 inclusive. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 35,446 | $14.00 | $496,244.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 1,936 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · derivative · entry 12 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,608 Underlying: Ordinary Shares · 1,936 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 1,936 | $32.04 | $62,029.44 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7). Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 22:47 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 1,936 | $14.00 | $27,104.00 |
DisclosureSEC source: 0001209191-21-046698 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 5,604 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,544 Underlying: Ordinary Shares · 5,604 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 5,604 | $32.23 | $180,616.92 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.76 inclusive. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 5,604 | $14.00 | $78,456.00 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 1,716 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · derivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,148 Underlying: Ordinary Shares · 1,716 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 1,716 | $32.14 | $55,152.24 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| May 06, 2021 Filed May 10, 2021 21:43 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 1,716 | $14.00 | $24,024.00 |
DisclosureSEC source: 0001209191-21-031355 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 897 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,864 Underlying: Ordinary Shares · 897 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 897 | $32.03 | $28,730.91 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.34 inclusive. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 897 | $14.00 | $12,558.00 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (right to buy) · Derivative | 3,391 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · derivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,761 Underlying: Ordinary Shares · 3,391 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 3,391 | $32.16 | $109,054.56 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:40 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 3,391 | $14.00 | $47,474.00 |
DisclosureSEC source: 0001209191-21-030350 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,406 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · derivative · entry 14 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,152 Underlying: Ordinary Shares · 30,406 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 26,635 | $30.88 | $822,488.80 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 11 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.27 to $31.02 inclusive. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 3,771 | $29.89 | $112,715.19 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 10 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,369 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.26 to $30.25 inclusive. Read SEC document |
| April 30, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 30,406 | $14.00 | $425,684.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 9 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,018 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · derivative · entry 13 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,558 Underlying: Ordinary Shares · 6,018 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 1,609 | $30.95 | $49,798.55 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 8 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.78 to $31.16 inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 4,409 | $30.35 | $133,813.15 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 7 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,343 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.77 to $30.76 inclusive. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionOrdinary Shares | 6,018 | $14.00 | $84,252.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,495 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · derivative · entry 12 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,576 Underlying: Ordinary Shares · 22,495 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 22:14 UTC | BICYCLE THERAPEUTICS PLC BCYC · Entity 5993 | SaleOrdinary Shares | 200 | $33.35 | $6,670.00 |
DisclosureSEC source: 0001209191-21-029349 · doc4.xml · nonDerivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,734 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.705 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.